Quick answers
- What is Pamelor?
- Pamelor is a brand name of Nortriptyline hydrochloride, a prescription medicine. The FDA NDC Directory lists 4 Pamelor products in 4 strengths and forms.
- Who makes Pamelor?
- Specgx LLC holds the FDA application for Pamelor (NDA018013, approved August 1, 1977).
- Is there a generic or store brand of Pamelor?
- Yes. The FDA NDC Directory lists 79 other products with the same active ingredients, strength and form as a Pamelor product, 79 of them generic. Ask your pharmacist whether one is right for you.
- Has Pamelor been recalled?
- No recall linked to Pamelor products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Pamelor is
Each Pamelor product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Nortriptyline hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| nortriptyline hydrochloride 10 mg capsule (oral) | Pamelor | 22 products, 16 companies | DailyMed |
| nortriptyline hydrochloride 25 mg capsule (oral) | Pamelor | 29 products, 22 companies | DailyMed |
| nortriptyline hydrochloride 50 mg capsule (oral) | Pamelor | 17 products, 12 companies | DailyMed |
| nortriptyline hydrochloride 75 mg capsule (oral) | Pamelor | 11 products, 9 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Nortriptyline hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA018013 | Specgx LLC | August 1, 1977 | 4 |
Companies that list Pamelor
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Pamelor products.
- SpecGx LLC4 products
Recalls
No recall linked to Pamelor products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.